Oligomenorrhoea

N14_OLIGOMEN

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N91.3, N91.4, N91.5 Hospital discharge: ICD-9 — 6261 Hospital discharge: ICD-8 — 6261 Cause of death: ICD-10 — N91.3, N91.4, N91.5 Cause of death: ICD-9 — 6261 Cause of death: ICD-8 — 6261 2 out of 7 registries used, show all original rules.	1522
4. Check minimum number of events None	1522
5. Include endpoints None	1522
6. Filter based on genotype QC (FinnGen only)	1522

Control definitions (FinnGen only)

Control exclude: N14_FEMALEGENNONINF

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	N14_OLIGOMEN
CONTROL_EXCLUDE	N14_FEMALEGENNONINF
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N91[3-5]
HD_ICD_9	6261
HD_ICD_8	6261
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N91[3-5]
COD_ICD_9	6261
COD_ICD_8	6261
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Oligomenorrhoea based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	10184	10184	-
Only index persons	9756	9756	-
Unadjusted period prevalence (%)
Whole population	0.29	0.29	-
Only index persons	0.36	0.36	-
Median age at first event (years)
Whole population	-	29.28	-
Only index persons	-	28.93	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1522	1522	-
Unadjusted period prevalence (%)	0.52	0.52	-
Median age at first event (years)	29.39	29.39	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1375: Matched controls
13750

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N91.4

ICD-10 Finland

Secondary oligomenorrhoea

1103.4

323.0

581

N91.5

ICD-10 Finland

Oligomenorrhoea, unspecified

233.1

322.6

322

G03DB01

ATC

dydrogesterone; oral

7.1

192.7

572

1253

N91.3

ICD-10 Finland

Primary oligomenorrhoea

470.9

170.7

167

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

5.1

161.0

689

2249

N97.0

ICD-10 Finland

Female infertility associated with anovulation

441.9

161.0

158

N97.9

ICD-10 Finland

Female infertility, unspecified

68.9

152.7

175

62611

ICD-8 Finland

Disorders of menstruation, Oligomenorrhoea

+∞

145.4

137

N91.1

ICD-10 Finland

Secondary amenorrhoea

34.6

140.4

184

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

25.3

136.6

195

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

6.9

119.9

334

612

LCA06

NOMESCO Finland

Biopsy of endometrium

12.3

119.3

227

218

62610

ICD-8 Finland

Disorders of menstruation, Hypomenorrhoea

+∞

112.0

106

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

22.1

109.7

163

N95.1

ICD-10 Finland

Menopausal and female climacteric states

+∞

89.6

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

9.0

80.8

180

226

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

13.8

77.4

137

109

N84.0

ICD-10 Finland

Polyp of corpus uteri

85.0

71.9

LA2AE

NOMESCO Finland

Ultrasound examination of ovarian cyst

133.9

71.7

6261A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Scanty or infrequent menstruation[HYPOMENORRHOEA]

+∞

67.2

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

7.3

63.6

162

248

8113

FHL

Fractional scraping

22.6

63.6

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

25.5

59.6

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

17.5

59.5

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

4.3

57.8

239

644

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

55.5

603

3213

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.8

55.2

454

2055

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

+∞

54.5

N95.0

ICD-10 Finland

Postmenopausal bleeding

20.3

51.1

A10BA02

ATC

metformin; oral

3.1

50.5

324

1236

TLC00

NOMESCO Finland

Insertion of intrauterine device

5.8

49.0

148

282

G03GA01

ATC

chorionic gonadotrophin; parenteral

11.1

47.5

N81.6

ICD-10 Finland

Rectocele

22.6

47.5

N87.0

ICD-10 Finland

Mild cervical dysplasia

82.9

43.1

XLA10

NOMESCO Finland

6.1

41.9

119

209

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

8.0

41.6

129

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

15.5

41.0

N92.4

ICD-10 Finland

Excessive bleeding in the premenopausal period

28.9

39.3

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

137.2

37.9

62699

ICD-8 Finland

Disorders of menstruation, Other

+∞

37.7

B02AA02

ATC

tranexamic acid; systemic

3.0

37.3

240

900

6261B

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Scanty or infrequent menstruation[OLIGOMENORRHOEA]

+∞

36.6

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

82.4

36.0

E66.01

ICD-10 Finland

Obesity due to excess calories

3.4

35.9

187

601

G03GA05

ATC

follitropin alfa; parenteral

12.9

35.2

ULC02

NOMESCO Finland

Hysteroscopy

9.8

35.1

N81.1

ICD-10 Finland

Cystocele

19.6

35.0

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

13.9

34.7

N97.4

ICD-10 Finland

Female infertility associated with male factors

+∞

34.5

TLW00

NOMESCO Finland

Insemination

345.3

34.1

N97.8

ICD-10 Finland

Female infertility of other origin

92.4

32.9

J02AC01

ATC

fluconazole; systemic

2.0

32.8

701

4711

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.9

32.8

217

824

G03GB02

ATC

clomifene; oral

10.1

31.8

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

4.5

31.8

117

276

LAA10

NOMESCO Finland

Percutaneous or transvaginal puncture and recovery of oocyte

54.2

31.4

G03GA02

ATC

human menopausal gonadotrophin; parenteral

12.4

30.4

N02AX02

ATC

tramadol; systemic, rectal

2.1

29.7

449

2600

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

29.6

327

1644

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.0

28.9

470

2797

N85.0

ICD-10 Finland

Endometrial glandular hyperplasia

105.7

28.8

62660

ICD-8 Finland

Disorders of menstruation, Intermenstrual bleeding

+∞

28.2

TLW10

NOMESCO Finland

Transfer of fresh embryo

+∞

28.2

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.5

28.2

247

1101

ULA02

NOMESCO Finland

Kolposcopy

3.1

27.8

163

568

G03DC02

ATC

norethisterone; oral

2.8

27.8

191

738

103

Kela drug reimbursment

Diabetes, insulin-treated

2.5

27.3

252

1153

62800

ICD-8 Finland

Sterility, female, Sterilitas primaria

+∞

27.2

N80.1

ICD-10 Finland

Endometriosis of ovary

76.7

26.9

N87.1

ICD-10 Finland

Moderate cervical dysplasia

276.2

26.8

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.9

26.4

514

3250

61520

ICD-8 Finland

Other diseases of ovary and Fallopian tube, Cysta (cystis) follicularis ovarii (retentio)

+∞

26.1

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

265.4

25.8

P01AB01

ATC

metronidazole; oral, rectal

1.9

25.5

559

3677

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.6

25.4

207

884

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

25.4

184

732

M54.5

ICD-10 Finland

Low back pain

1.9

25.3

462

2842

LEF00

NOMESCO Finland

Anterior colporraphy with sutures for primary cystocele

71.2

24.9

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

24.5

241

1134

6266A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia

+∞

24.0

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

12.3

23.9

JAH01

NOMESCO Finland

Laparoscopy

5.0

23.7

164

N83.0

ICD-10 Finland

Follicular cyst of ovary

24.1

23.5

E66.8

ICD-10 Finland

Other obesity

3.6

23.4

110

324

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

6.4

23.2

101

6262A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Excessive or frequent menstruation[HYPERMENORRHOEA]

+∞

23.0

62620

ICD-8 Finland

Disorders of menstruation, Excessive

+∞

23.0

H03AA01

ATC

levothyroxine sodium; systemic

2.0

22.8

361

2088

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.2

22.8

263

1333

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

3.1

22.6

133

461

M79.6

ICD-10 Finland

Pain in limb

1.9

22.5

460

2920

SPAT1262

SPAT

Handing over of treatment supplies

2.4

22.1

202

913

G03DA04

ATC

progesterone; systemic, rectal, vaginal

5.5

21.8

122

N05AH04

ATC

quetiapine; oral

2.1

21.8

268

1394

A02BC05

ATC

esomeprazole; systemic

1.8

21.7

463

2974

LBF01

NOMESCO Finland

Laparoscopic perfusion of Fallopian tube

116.9

21.6

A02BC02

ATC

pantoprazole; systemic

1.7

21.6

757

5686

UJF32

NOMESCO Finland

Coloscopy

2.2

21.5

252

1281

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.5

21.5

105

319

N83.1

ICD-10 Finland

Corpus luteum cyst

44.1

21.4

H02AB06

ATC

prednisolone; systemic

1.8

21.4

565

3883

J01MA02

ATC

ciprofloxacin; systemic

1.9

21.2

413

2567

G47.3

ICD-10 Finland

Sleep apnoea

2.4

21.1

188

837

E28.3

ICD-10 Finland

Primary ovarian failure

28.5

21.0

N80.0

ICD-10 Finland

Endometriosis of uterus

37.8

20.8

N06AB03

ATC

fluoxetine; oral

2.3

20.8

202

941

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

20.6

279

1511

J01DB01

ATC

cefalexin; oral

1.9

20.5

1103

9389

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.4

20.5

184

821

N02BE01

ATC

paracetamol; systemic, rectal

1.9

20.2

1108

9459

H01CA02

ATC

nafarelin; nasal

10.0

20.2

N03AX16

ATC

pregabalin; oral

2.1

20.1

268

1437

N91.2

ICD-10 Finland

Amenorrhoea, unspecified

11.9

19.8

E66.00

ICD-10 Finland

Metabolic syndrome

4.1

19.8

197

N06AB06

ATC

sertraline; oral

2.4

19.7

185

845

T90

ICPC

Diabetes non-insulin dependent

2.3

19.5

196

926

N03AG01

ATC

valproic acid; systemic, rectal

3.2

19.4

105

344

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

19.3

136

531

R03AC02

ATC

salbutamol; inhalant

1.7

19.1

713

5371

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

19.1

746

5696

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

18.8

244

1292

TLW12

NOMESCO Finland

Insertion of frozen embryo

+∞

18.8

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.9

18.7

346

2095

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

18.4

409

2631

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

18.3

685

5142

N06AX11

ATC

mirtazapine; oral

1.8

18.2

390

2480

N80.9

ICD-10 Finland

Endometriosis, unspecified

22.0

18.2

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

18.1

189

908

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

18.0

169

769

L68.0

ICD-10 Finland

Hirsutism

8.5

18.0

Z3231

NOMESCO Finland

Registered nurse

1.9

17.9

319

1903

N03AX12

ATC

gabapentin; oral

2.3

17.9

176

823

N05BA04

ATC

oxazepam; oral

1.8

17.8

335

2039

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

17.7

121

464

N06AX16

ATC

venlafaxine; oral

2.1

17.7

218

1129

A02BC01

ATC

omeprazole; systemic

1.9

17.6

310

1841

N06AB04

ATC

citalopram; systemic

1.9

17.4

288

1672

R51.80

ICD-10 Finland

Headache

2.0

17.2

236

1275

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.6

17.1

127

512

E66.9

ICD-10 Finland

Obesity, unspecified

3.7

17.0

210

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

10.9

17.0

R06.0

ICD-10 Finland

Dyspnoea

1.9

17.0

265

1505

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

16.9

228

1219

M01AE02

ATC

naproxen; oral, rectal

1.6

16.8

770

6043

J01DA01

ATC

[U] cefalexin; systemic

1.6

16.8

816

6505

G03FB06

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

2.6

16.8

125

504

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

16.8

249

1386

N92.5

ICD-10 Finland

Other specified irregular menstruation

4.1

16.6

169

R53

ICD-10 Finland

Malaise and fatigue

1.9

16.5

265

1518

LBF00

NOMESCO Finland

Perfusion of Fallopian tube

172.0

16.5

LA2HE

NOMESCO Finland

Repeated measurement of ovarian cyst

172.0

16.5

N03AX09

ATC

lamotrigine; oral

2.9

16.5

101

361

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

16.4

707

5446

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

16.3

353

2236

Z2221

NOMESCO Finland

Medical doctor

1.8

16.1

363

2331

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

48.1

16.0

R42

ICD-10 Finland

Dizziness and giddiness

2.0

16.0

238

1322

N06AB10

ATC

escitalopram; oral

1.8

16.0

331

2068

AA1AD

NOMESCO Finland

CT of head and brain

2.0

15.7

210

1121

LEF13

NOMESCO Finland

Colpoperineoplasty and vaginal hysterectomy

+∞

15.6

62630

ICD-8 Finland

Disorders of menstruation, Painful

+∞

15.6

62650

ICD-8 Finland

Disorders of menstruation, Irregular

+∞

15.6

N97.1

ICD-10 Finland

Female infertility of tubal origin

+∞

15.6

UKC02

NOMESCO Finland

Cystoscopy

2.8

15.6

104

392

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

26.6

15.6

E22.1

ICD-10 Finland

Hyperprolactinaemia

8.3

15.6

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

15.5

336

2122

N81.5

ICD-10 Finland

Vaginal enterocele

161.7

15.5

WX110

NOMESCO Finland

Local anesthesy

1.6

15.5

936

7807

J01AA02

ATC

doxycycline; systemic

1.6

15.4

943

7886

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

45.5

15.1

C03CA01

ATC

furosemide; systemic

2.0

15.0

197

1042

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

15.0

993

8440

N05AX12

ATC

aripiprazole; systemic

3.1

15.0

288

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

15.0

223

1239

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

14.9

291

1778

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.0

14.9

308

1410

FHL

Laparoscopy

5.9

14.9

G03GA06

ATC

follitropin beta; parenteral

6.8

14.8

D01

ICPC

Abdominal pain/cramps general

2.1

14.8

175

884

A02BC03

ATC

lansoprazole; oral

1.8

14.8

292

1790

R01AD09

ATC

mometasone; nasal

1.6

14.8

629

4782

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

2.3

14.7

141

650

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.9

14.7

158

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

14.7

113

465

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

2.8

14.6

371

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

14.6

535

3914

121

Kela drug reimbursment

Severe hypofunction of sexual glands

6.5

14.5

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.3

14.5

126

R06AE07

ATC

cetirizine; oral

1.6

14.4

633

4836

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

5.1

14.4

LAC21

NOMESCO Finland

Laparoscopic destruction of lesion of ovary

27.5

14.3

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

14.3

947

7992

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

14.2

149

715

N06AX21

ATC

duloxetine; oral

2.2

14.2

146

694

M01AB05

ATC

diclofenac; systemic, rectal

1.6

13.9

792

6418

R2110

NOMESCO Finland

Giving the first information

2.6

13.9

104

419

T82

ICPC

Obesity

3.2

13.9

236

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

13.9

113

477

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

13.9

194

1050

P03

ICPC

Feeling depressed

2.0

13.8

182

963

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

13.8

568

4260

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

13.7

305

1935

J01CA08

ATC

pivmecillinam; oral

1.5

13.7

683

5359

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.1

13.6

134

G01AA10

ATC

clindamycin; vaginal

1.8

13.6

258

1558

M01AH05

ATC

etoricoxib; oral

1.5

13.6

685

5382

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

13.6

170

879

6202X

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other and unspecified ovarian cyst

+∞

13.6

D25.0

ICD-10 Finland

Submucous leiomyoma of uterus

4.9

13.5

61610

ICD-8 Finland

Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female

34.4

13.5

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.1

13.5

241

H01CC01

ATC

ganirelix; parenteral

5.7

13.5

M79.1

ICD-10 Finland

Myalgia

2.0

13.4

187

1009

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.3

13.4

127

581

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

13.4

277

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.8

13.3

237

1400

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.8

13.2

313

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

6.9

13.2

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.0

13.2

274

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

13.1

520

3846

K04.08

ICD-10 Finland

Other specified pulpit

2.4

13.1

109

467

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.6

13.1

401

E0000UV

ATC

1.6

13.1

524

3891

N05CF01

ATC

zopiclone; oral

1.7

13.0

331

2181

SPAT1260

SPAT

Consultation of another employee

1.8

13.0

233

1380

L17

ICPC

Foot/toe symptom/complaint

1.7

12.9

294

1876

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.8

12.8

228

1348

N76.0

ICD-10 Finland

Acute vaginitis

2.2

12.7

132

631

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

12.7

232

1380

TLC02

NOMESCO Finland

Simple extraction of IUD

3.0

12.5

254

N80.4

ICD-10 Finland

Endometriosis of rectovaginal septum and vagina

+∞

12.5

62801

ICD-8 Finland

Sterility, female, Sterilitas secundaria

+∞

12.5

62530

ICD-8 Finland

Other diseases of uterus, Endometriosis ovarii

+∞

12.5

N05AH03

ATC

olanzapine; systemic

2.5

12.5

394

SPAT1263

SPAT

Sampling

1.5

12.5

574

4385

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

5.2

12.5

C07AA05

ATC

propranolol; systemic

1.8

12.5

262

1628

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

12.4

729

5878

XKD00

NOMESCO Finland

Uroflowmetry

3.9

12.4

131

M25.5

ICD-10 Finland

Pain in joint

1.6

12.4

353

2396

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.8

12.3

142

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

12.3

216

1269

M03BX02

ATC

tizanidine; oral

1.5

12.3

766

6255

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.2

12.3

212

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.8

12.2

291

LCA16

NOMESCO Finland

Destruction of endometrium

37.9

12.2

Z71.8

ICD-10 Finland

Other specified counselling

1.6

12.1

338

2280

E66

ICD-10 Finland

Obesity

2.8

12.1

278

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.9

12.0

130

X05

ICPC

Menstruation absent/scanty

4.6

12.0

N05CD07

ATC

temazepam; oral

2.4

12.0

101

434

F50.9

ICD-10 Finland

Eating disorder, unspecified

4.4

11.9

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

11.9

434

3130

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

11.9

335

R50.9

ICD-10 Finland

Fever, unspecified

2.0

11.9

162

869

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

11.8

683

5468

SGA01

NOMESCO Finland

Tooth opening as first aid

1.8

11.8

223

1341

N06AA09

ATC

amitriptyline; systemic

2.4

11.7

103

456

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

11.7

166

903

F50.3

ICD-10 Finland

Atypical bulimia nervosa

6.9

11.6

Z01.2

ICD-10 Finland

Dental examination

1.5

11.6

578

4474

M79.7

ICD-10 Finland

Fibromyalgia

3.1

11.6

216

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.1

11.6

139

706

J01FF01

ATC

clindamycin; systemic

1.7

11.5

298

1967

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

11.5

147

767

LAA06

NOMESCO Finland

Transvaginal puncture of ovarian cyst

+∞

11.5

N98.1

ICD-10 Finland

Hyperstimulation of ovaries

+∞

11.5

N83.5

ICD-10 Finland

Torsion of ovary, ovarian pedicle and fallopian tube

121.0

11.4

A10AE04

ATC

insulin glargine; parenteral

2.5

11.4

395

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.9

11.4

121

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.1

11.4

201

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

11.3

395

2814

N06AX12

ATC

bupropion; oral

2.3

11.3

106

484

J01EA01

ATC

trimethoprim; systemic

1.6

11.3

354

2454

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

11.3

185

1060

G03GA04

ATC

urofollitropin; parenteral

35.3

11.3

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

11.3

472

3508

A06AD11

ATC

lactulose; oral

2.2

11.3

117

558

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

11.3

105

477

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

11.2

344

2369

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

11.2

407

2923

1413

FHL

Laparoscopy and other therapeutic procedure

6.0

11.2

L03

ICPC

Low back symptom/complaint

1.6

11.2

312

2095

J01CA04

ATC

amoxicillin; systemic

1.6

11.2

1132

10193

S18

ICPC

Laceration/cut

1.5

11.1

421

3056

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

11.1

337

2315

A01

ICPC

Pain general/multiple sites

2.4

11.1

389

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.2

11.1

183

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

11.0

122

598

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.9

11.0

155

841

N05BA01

ATC

diazepam; systemic, rectal

2.0

11.0

141

737

C07AB07

ATC

bisoprolol; oral

1.6

10.9

365

2565

M54.3

ICD-10 Finland

Sciatica

2.7

10.9

295

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

10.9

764

6325

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

10.8

210

1270

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.7

10.8

274

J20

ICD-10 Finland

Acute bronchitis

2.1

10.8

121

599

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

10.8

267

N05AA02

ATC

levomepromazine; systemic

3.4

10.8

154

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

10.7

381

2716

R05

ICPC

Cough

1.6

10.7

303

2043

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

10.7

290

1931

N94.1

ICD-10 Finland

Dyspareunia

7.6

10.7

K07.60

ICD-10 Finland

Snapping jaw

2.3

10.7

417

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.7

10.6

124

N85.1

ICD-10 Finland

Endometrial adenomatous hyperplasia

60.5

10.6

N96

ICD-10 Finland

Habitual aborter

60.5

10.6

G44.2

ICD-10 Finland

Tension-type headache

1.8

10.6

189

1111

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.9

10.6

233

A02BA02

ATC

ranitidine; systemic

1.9

10.6

170

966

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

10.5

308

2092

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

10.5

309

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

10.5

419

3068

ZXA10

NOMESCO Finland

Bilateral

1.8

10.5

187

1103

WX290

NOMESCO Finland

Other blockade of nerve

1.5

10.4

641

5143

Z31.1

ICD-10 Finland

Artificial insemination

110.8

10.4

6171A

ICD-9 Finland

Endometriosis of ovary

+∞

10.4

2564A

ICD-9 Finland

Ovarian dysfunction, Polycystic ovaries

+∞

10.4

LCA30

NOMESCO Finland

Transfer of oocyte or embryo to uterus in assisted fertilisation

+∞

10.4

6173B

ICD-9 Finland

Endometriosis of pelvic peritoneum[ENDOMETRIOSIS RETROUTERINA]

+∞

10.4

A10BJ06

ATC

semaglutide; parenteral

4.6

10.4

WX402

NOMESCO Finland

General anaesthesia

1.8

10.4

184

1081

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

10.3

115

565

F50.0

ICD-10 Finland

Anorexia nervosa

5.4

10.3

C10AA05

ATC

atorvastatin; oral

1.7

10.3

250

1616

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

4.8

10.3

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

10.3

408

2984

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

10.3

409

2991

LDA10

NOMESCO Finland

Curettage of cervix uteri

3.0

10.3

204

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

10.3

363

2584

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

10.2

101

472

G03HB01

ATC

cyproterone and estrogen; systemic

1.7

10.2

234

1487

K30

ICD-10 Finland

Functional dyspepsia

2.0

10.2

127

656

G04BD08

ATC

solifenacin; oral

2.9

10.2

212

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.9

10.2

206

H02AB04

ATC

methylprednisolone; systemic

1.9

10.1

156

873

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.4

10.1

360

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

4.4

10.0

K08.80

ICD-10 Finland

Toothache NOS

2.1

10.0

118

597

8305

FHL

Supravaginal amputation or resection

7.3

10.0

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

10.0

181

1071

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

5.6

10.0

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

10.0

165

945

N05AB03

ATC

perphenazine; systemic, rectal

3.1

9.9

170

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

9.9

197

1201

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.0

9.9

125

649

G04BD12

ATC

mirabegron; oral

2.6

9.9

283

U07

ICPC

Urine symptom/complaint other

2.7

9.8

259

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

9.8

336

2368

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

9.8

381

R51

ICD-10 Finland

Headache

2.4

9.8

353

N05AX08

ATC

risperidone; systemic

2.2

9.8

461

Z2445

NOMESCO Finland

Psychologist

2.6

9.8

278

LAC01

NOMESCO Finland

Laparoscopic excision of ovarian cyst

9.6

9.8

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

9.8

233

1498

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.4

9.7

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

9.7

113

566

R60.0

ICD-10 Finland

Localized oedema

2.1

9.7

104

504

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

9.7

422

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.1

9.7

173

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

9.6

131

700

P01

ICPC

Feeling anxious/nervous/tense

1.7

9.6

210

1316

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

9.6

332

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

9.6

240

1559

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

9.6

449

3390

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.1

9.6

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

3.6

9.6

115

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.8

9.6

227

SPAT1312

SPAT

General health counselling

1.5

9.5

455

3454

R33

ICD-10 Finland

Retention of urine

3.8

9.4

101

L02BG04

ATC

letrozole; oral

2.3

9.4

402

C09CA06

ATC

candesartan; oral

1.7

9.4

205

1283

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

4.2

9.4

62600

ICD-8 Finland

Disorders of menstruation, Absent

+∞

9.4

6271A

ICD-9 Finland

Menopausal and postmenopausal disorders, Postmenopausal bleeding

+∞

9.4

6170A

ICD-9 Finland

Endometriosis of uterus

+∞

9.4

N91.0

ICD-10 Finland

Primary amenorrhoea

+∞

9.4

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.8

9.4

182

1098

D07AC13

ATC

mometasone; topical

1.5

9.3

337

2402

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.8

9.3

151

861

XCK10

NOMESCO Finland

Photography of fundus of eye

2.2

9.3

431

N30.0

ICD-10 Finland

Acute cystitis

1.7

9.3

188

1152

E66.0

ICD-10 Finland

Obesity due to excess calories

6.5

9.3

Z00.0

ICD-10 Finland

General medical examination

1.7

9.2

213

1355

N39.3

ICD-10 Finland

Stress incontinence

2.3

9.2

360

G03DC03

ATC

lynestrenol; oral

3.7

9.2

104

LEB00

NOMESCO Finland

Biopsy of vagina

6.8

9.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.7

9.1

239

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

9.1

151

865

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

9.1

125

671

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

9.1

191

1181

AN1

Coronary angiography

2.7

9.1

233

LCB98

NOMESCO Finland

Other transluminal endoscopic excision of lesion of uterus

15.7

9.0

C10AA01

ATC

simvastatin; oral

1.6

9.0

266

1805

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.3

9.0

132

A10BK03

ATC

empagliflozin; oral

2.8

9.0

203

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

5.1

9.0

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

3.9

9.0

H02AB09

ATC

hydrocortisone; systemic

3.8

9.0

N90.8

ICD-10 Finland

Other specified noninflammatory disorders of vulva and perineum

18.7

8.9

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

8.9

114

596

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

8.9

101

502

N03AF02

ATC

oxcarbazepine; oral

3.2

8.9

144

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.1

8.9

161

R03DC03

ATC

montelukast; oral

1.7

8.9

202

1280

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.6

8.9

112

ZXE00

NOMESCO Finland

One hour or less

1.4

8.9

475

3674

J01FA10

ATC

azithromycin; systemic

1.4

8.9

807

6889

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

8.9

332

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.9

8.9

R02

ICPC

Shortness of breath/dyspnoea

1.9

8.8

131

725

WX002

NOMESCO Finland

Sedation and analgesia

1.7

8.7

172

1044

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.9

8.7

132

735

SPAT1097

SPAT

Recording of ECG

1.9

8.7

124

674

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

8.7

528

4178

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

8.7

492

Z31.2

ICD-10 Finland

In vitrofertilization

50.3

8.7

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

8.7

310

SPAT1310

SPAT

Counselling related to known health issue

1.5

8.7

404

3038

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

8.6

127

697

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

8.6

482

R35

ICD-10 Finland

Polyuria

3.1

8.6

148

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.5

8.6

285

D07AD01

ATC

clobetasol; topical

1.8

8.6

162

972

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

9.0

8.5

G04BD07

ATC

tolterodine; oral

3.0

8.5

155

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.9

8.5

122

664

1350

FHL

Hysteroscopy

27.7

8.5

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.2

8.5

133

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

6.0

8.5

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

8.4

281

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.8

8.4

185

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.2

8.4

423

SPAT1301

SPAT

No procedures

1.5

8.4

372

2762

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.5

8.4

N83.9

ICD-10 Finland

Noninflammatory disorder of ovary, fallopian tube and broad ligament, unspecified

+∞

8.3

6289A

ICD-9 Finland

Infertility, female, Of unspecified origin[STERILITAS ET INFERTILITAS MULIERIS NUD PRIM]

+∞

8.3

25690

ICD-8 Finland

Ovarian dysfunction, Syndroma Stein-Leventhal

+∞

8.3

6173A

ICD-9 Finland

Endometriosis of pelvic peritoneum[ENDOMETRIOSIS SEROSAE PELVIS]

+∞

8.3

A01AB09

ATC

miconazole; local oral

2.0

8.3

503

ZXD05

NOMESCO Finland

Urgent procedure

1.5

8.3

392

2948

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

8.3

190

WZA90

NOMESCO Finland

Other doctors statement

1.5

8.3

291

2054

A10AE05

ATC

insulin detemir; parenteral

2.5

8.3

267

-1

NOMESCO Finland

1.4

8.3

480

3761

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

8.3

126

703

SPAT1153

SPAT

Removal of sutures

1.5

8.3

304

2169

C05AA08

ATC

fluocortolone; rectal, topical

1.8

8.3

133

754

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

8.2

305

2180

J01MA12

ATC

levofloxacin; systemic

1.8

8.2

157

941

C10AA07

ATC

rosuvastatin; oral

1.7

8.2

162

982

D06

ICPC

Abdominal pain localized other

2.0

8.2

110

584

K02.1

ICD-10 Finland

Caries of dentine

1.4

8.2

772

6589

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.1

8.2

409

G03FB08

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

2.3

8.2

341

K59.0

ICD-10 Finland

Constipation

2.6

8.2

225

W15

ICPC

Infertility/subfertility female

7.6

8.2

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

3.1

8.2

137

LCA10

NOMESCO Finland

Curettage of body of uterus

6.1

8.2

R07.3

ICD-10 Finland

Other chest pain

2.1

8.1

478

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

8.1

419

3203

N01

ICPC

Headache

1.7

8.1

179

1123

R52.9

ICD-10 Finland

Pain, unspecified

2.1

8.1

452

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

8.1

194

1244

N05AF03

ATC

chlorprothixene; systemic

3.1

8.1

138

ZY010

NOMESCO Finland

Hospital outpatient

2.2

8.1

370

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

8.1

107

567

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.9

8.0

113

613

A10BH01

ATC

sitagliptin; oral

2.4

8.0

277

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

8.0

144

850

R11

ICD-10 Finland

Nausea and vomiting

2.0

8.0

103

540

J01FA06

ATC

roxithromycin; oral

1.4

7.9

465

3641

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.9

7.9

162

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.8

7.9

175

T89

ICPC

Diabetes insulin dependent

2.6

7.9

217

F50.1

ICD-10 Finland

Atypical anorexia nervosa

5.2

7.9

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

3.7

7.9

R03BA05

ATC

fluticasone; inhalant

1.6

7.9

223

1497

SPAT1229

SPAT

Assessment of need for aid

2.3

7.9

294

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

10.9

7.8

N03AE01

ATC

clonazepam; systemic

2.4

7.8

267

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.0

7.8

P76

ICPC

Depressive disorder

1.9

7.8

105

561

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

3.9

7.8

XQ800

NOMESCO Finland

Prick test

1.9

7.8

115

637

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

7.8

376

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.7

7.7

153

929

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

7.7

297

SPAT1216

SPAT

Assessment of functional ability

1.8

7.7

129

742

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.8

7.7

181

R05

ICD-10 Finland

Cough

1.6

7.7

204

1344

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

7.7

344

F50.2

ICD-10 Finland

Bulimia nervosa

5.3

7.7

R4190

NOMESCO Finland

Nutritional therapy

2.8

7.7

166

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

7.7

1197

11149

SPAT1240

SPAT

Therapeutic discussion

1.6

7.7

184

1182

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

7.7

336

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.4

7.6

105

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

7.6

121

685

J05AB11

ATC

valaciclovir; oral

1.7

7.6

157

966

F34.1

ICD-10 Finland

Dysthymia

2.6

7.6

209

G50.1

ICD-10 Finland

Atypical facial pain

4.2

7.6

F61.0

ICD-10 Finland

Mixed personality disorders

3.6

7.6

N84.1

ICD-10 Finland

Polyp of cervix uteri

11.9

7.6

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

7.6

131

762

78629

ICD-8 Finland

Symptoms referable to genito-urinary system, Incontinentia urinae

25.1

7.6

L02AE01

ATC

buserelin; implant, nasal, parenteral

10.1

7.5

M02AA07

ATC

piroxicam; topical

1.5

7.5

334

2474

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.7

7.5

179

N06AG02

ATC

moclobemide; oral

2.7

7.5

179

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

3.5

7.5

A97

ICPC

No disease

1.6

7.5

176

1124

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

7.5

103

556

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

7.5

125

722

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

4.3

7.4

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

2.7

7.4

182

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

7.4

436

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

3.4

7.3

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.8

7.3

131

773

N05CF02

ATC

zolpidem; oral

1.6

7.3

191

1255

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.2

7.3

62532

ICD-8 Finland

Other diseases of uterus, Endometriosis retro-cervicalis sive retrouterina

+∞

7.3

61521

ICD-8 Finland

Other diseases of ovary and Fallopian tube, Cysta (cystis) corporis lutei ovarii

+∞

7.3

N89.6

ICD-10 Finland

Tight hymenal ring

+∞

7.3

LEF40

NOMESCO Finland

Vaginal repair of enterocele

+∞

7.3

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.8

7.3

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

7.3

417

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

7.2

203

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.5

7.2

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

7.2

534

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

7.2

330

2455

S06.0

ICD-10 Finland

Concussion

1.8

7.2

112

631

Z30.2

ICD-10 Finland

Sterilization

1.8

7.2

126

738

D07AC01

ATC

betamethasone; topical

1.4

7.2

357

2700

B01AB05

ATC

enoxaparin; parenteral

1.5

7.2

273

1959

104

Kela drug reimbursment

Thyroid insufficiency

2.0

7.1

441

KMAK

NOMESCO Finland

1.4

7.1

717

6122

G03FB05

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

1.8

7.1

113

642

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

7.1

941

8402

N18

ICPC

Paralysis/weakness

5.7

7.1

21899

ICD-8 Finland

Uterine fibroma

3.1

7.0

118

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.6

7.0

195

1297

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

7.0

488

3918

T78.4

ICD-10 Finland

Allergy, unspecified

2.2

7.0

337

L28

ICPC

Limited function/disability (L)

1.8

7.0

124

728

J01FA09

ATC

clarithromycin; systemic

1.4

6.9

382

2945

N06AA12

ATC

doxepin; systemic

2.5

6.9

203

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

6.9

141

UJD02

NOMESCO Finland

Gastroscopy

2.7

6.9

164

SGA05

NOMESCO Finland

Very demanding and lengthy opening and dilatation of root canal of tooth

2.0

6.9

447

SPAT1254

SPAT

Administration of medicine

1.6

6.9

164

1052

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

6.9

125

740

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.4

6.9

223

N05AN01

ATC

lithium; oral

3.0

6.9

126

E03

ICD-10 Finland

Other hypothyroidism

2.1

6.9

343

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

6.9

255

P99

ICPC

Psychological disorders other

2.6

6.8

180

183

Kela drug reimbursment

Lamotrigin and topiramate

5.1

6.8

N06AB08

ATC

fluvoxamine; oral

3.1

6.8

110

N05BE01

ATC

buspirone; oral

3.1

6.8

110

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

6.8

160

1022

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.8

6.8

150

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.6

6.8

XKC03

NOMESCO Finland

Water cystometry

3.6

6.8

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

9.4

6.8

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

6.8

312

2322

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

5.7

6.8

T83

ICPC

Overweight

3.2

6.8

105

Z3226

NOMESCO Finland

Physiotherapist

1.6

6.8

185

1227

WX704

NOMESCO Finland

Intubation

2.1

6.8

338

Z2446

NOMESCO Finland

Social worker

2.0

6.7

388

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

6.7

127

759

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

6.7

134

817

X07

ICPC

Menstruation irregular/frequent

3.1

6.7

111

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

6.7

113

652

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.1

6.7

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

6.7

102

569

6421

FHL

Appendicectomy

2.3

6.7

272

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.5

6.7

204

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

6.7

111

640

S10

ICPC

Boil/carbuncle

2.3

6.7

265

N04BC05

ATC

pramipexole; oral

2.2

6.6

286

N03AF01

ATC

carbamazepine; oral, rectal

2.5

6.6

206

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.8

6.6

116

678

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.9

6.6

133

N06AB05

ATC

paroxetine; oral

2.1

6.6

370

M89.0

ICD-10 Finland

Algoneurodystrophy

5.9

6.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

6.6

455

KH1AD

NOMESCO Finland

CT of urinary organs

3.3

6.6

X15

ICPC

Vaginal symptom/complaint other

2.1

6.6

335

R06AX27

ATC

desloratadine; oral

1.4

6.6

376

2912

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

6.6

275

2006

N80

ICD-10 Finland

Endometriosis

12.3

6.6

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

6.6

267

1935

G02CB01

ATC

bromocriptine; systemic

3.1

6.6

113

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

6.6

110

634

21900

ICD-8 Finland

Other benign neoplasm of uterus, Papiloma, polyp

8.7

6.6

L01

ICPC

Neck symptom/complaint

1.6

6.6

171

1120

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

6.5

260

LCB14

NOMESCO Finland

Laparoscopic myolysis

10.1

6.5

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

6.5

328

SPAT1234

SPAT

Support of social functional capacity

2.4

6.5

210

C03DA01

ATC

spironolactone; oral

2.0

6.5

379

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

6.5

464

K04.0

ICD-10 Finland

Pulpitis

1.7

6.5

133

815

R01AD08

ATC

fluticasone; nasal

1.4

6.5

349

2673

F50.8

ICD-10 Finland

Other eating disorders

5.7

6.5

N85.7

ICD-10 Finland

Haematometra

70.2

6.4

1411

FHL

Laparoscopy and cyst puncture

70.2

6.4

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

6.4

212

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

6.4

740

6408

X58

ICD-10 Finland

Exposure to other specified factors

1.7

6.4

142

890

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

6.4

469

A04

ICPC

Weakness/tiredness general

1.6

6.4

159

1027

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.0

6.4

110

D11

ICPC

Diarrhoea

1.6

6.4

154

988

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

6.4

236

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

6.4

132

813

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

2.0

6.4

418

G04BD04

ATC

oxybutynin; oral, transdermal

2.4

6.3

226

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

6.3

195

1329

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

6.3

492

C08CA05

ATC

nifedipine; systemic

2.3

6.3

246

8201

FHL

Ovarian preservation exploration and related procedures, eg resection, enucleation or ovariolysis

8.2

6.3

N03AX11

ATC

topiramate; oral

2.6

6.3

163

N06AX03

ATC

mianserin; oral

2.4

6.3

200

LDA00

NOMESCO Finland

Dilatation of cervix uteri

11.1

6.3

C539, 6666, 0

ICD-O-3

11.1

6.3

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

9.3

6.3

A77

ICPC

Viral disease other/NOS

2.2

6.3

272

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

6.3

281

X14

ICPC

Vaginal discharge

2.5

6.3

182

L02

ICPC

Back symptom/complaint

1.7

6.3

118

708

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

6.3

261

62400

ICD-8 Finland

Malposition of uterus, Retroversion and retroflexion

+∞

6.3

62533

ICD-8 Finland

Other diseases of uterus, Adenomyosis uteri

+∞

6.3

62698

ICD-8 Finland

Disorders of menstruation, Alia definita

+∞

6.3

6227A

ICD-9 Finland

Noninflammatory disorders of cervix, Mucous polyp of cervix

+∞

6.3

N85.6

ICD-10 Finland

Intrauterine synechiae

+∞

6.3

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

6.2

221

A07AA02

ATC

nystatin; oral

2.3

6.2

253

H01CC02

ATC

cetrorelix; parenteral

26.8

6.2

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

6.2

296

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

7.1

6.2

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

6.2

242

P29

ICPC

Psychological sympt/compl other

1.8

6.2

100

571

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.0

6.2

373

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

5.1

6.2

H02AB07

ATC

prednisone; oral

1.7

6.2

138

868

A02BX02

ATC

sucralfate; oral

3.0

6.2

113

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.7

6.1

138

870

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

5.8

6.1

U01

ICPC

Dysuria/painful urination

1.8

6.1

101

581

M54.2

ICD-10 Finland

Cervicalgia

2.0

6.1

395

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.9

6.1

123

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

6.1

567

SBA00

NOMESCO Finland

Microbiological examinations

3.3

6.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

6.1

397

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

6.1

516

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

6.1

271

R61

ICD-10 Finland

Hyperhidrosis

8.6

6.1

XKD03

NOMESCO Finland

Urethral pressure profilometry

4.4

6.0

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

6.0

238

1713

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3009214) Lutropin [Units/volume] in Serum or Plasma

225

230

11.31

200.67

1.4

1.3

u/l

9.3

13.1

2.35

180

178

(3017446) Testosterone [Moles/volume] in Serum or Plasma

148

112

14.53

159.02

1.5

1.4

nmol/l

1.4

2.2

0.92

122

(3021387) Prolactin [Units/volume] in Serum or Plasma

275

555

5.83

133.45

1.8

1.7

mu/l

306.2

362.6

1.57

249

480

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

141

139

11.08

127.79

1.4

1.2

ug/l

4.5

3.8

0.32

133

121

(3023323) Follitropin [Units/volume] in Serum or Plasma

262

754

3.99

80.14

1.6

1.3

iu/l

14.4

23.7

6.23

214

646

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

111

173

6.84

68.83

1.7

1.5

nmol/l

0.3

0.11

134

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

147

6.52

54.40

1.5

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1312

10282

3.00

50.14

5.6

4.1

pmol/l

14.4

0.39

1235

9501

(3013826) Glucose [Moles/volume] in Serum or Plasma

896

5995

2.20

48.17

4.9

3.8

mmol/l

6.6

6.3

1.85

821

5324

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

209

5.00

44.44

1.3

1.4

u/l

9.5

26.2

9.75

178

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1108

8261

2.25

42.90

8.0

6.4

u/l

76.7

73.8

1.50

1053

7782

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

533

3011

2.19

42.84

3.0

2.2

u/l

60.2

57.6

0.13

502

2748

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

784

5142

2.08

42.36

5.6

5.5

umol/l

9.1

10.3

4.14

739

4823

(3036481) Cortisol [Moles/volume] in Serum or Plasma

253

1063

2.66

39.48

2.3

2.1

nmol/l

371.5

382.7

0.40

232

973

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1396

11794

3.22

37.43

6.8

4.7

mu/l

1.7

1.8

2.23

1326

11069

(3031040) Bacteria [#/volume] in Urine by Automated count

1065

8012

2.10

37.42

5.6

3.7

e6/l

2183.2

2704.4

0.09

(3026008) Bacteria identified in Urine by Culture

577

3500

2.04

37.32

3.7

2.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

439

2473

2.09

34.18

1.9

1.7

mg/l

0.8

1.0

1.88

314

1808

(3019550) Sodium [Moles/volume] in Serum or Plasma

1389

11893

2.92

32.56

16.4

10.2

mmol/l

139.4

139.5

1.95

1368

11499

(3023103) Potassium [Moles/volume] in Serum or Plasma

1392

11944

2.94

32.26

16.5

10.2

mmol/l

3.9

0.67

1367

11511

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

22.15

32.24

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

903

6641

1.88

30.93

10.7

8.8

e9/l

4.1

4.0

0.66

806

5824

(3005082) Progesterone [Moles/volume] in Serum or Plasma

7.97

30.73

1.5

1.2

nmol/l

25.8

22.1

0.32

(3037467) Urinalysis macro (dipstick) panel - Urine

1069

8356

1.94

29.74

5.7

3.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1217

9954

2.11

29.70

6.3

4.2

mmol/mol

39.5

37.8

6.31

1154

9332

(3009261) Glucose [Presence] in Urine by Test strip

819

5914

1.83

28.97

4.3

3.1

estimate

0.0

0.50

141

1167

(3013707) Erythrocyte sedimentation rate by Westergren method

1084

8576

1.92

28.26

4.5

3.6

mm/h

11.9

10.8

1.91

1015

7998

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

512

3217

1.89

28.12

1.4

1.3

u/ml

1.8

1.7

0.05

142

876

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

495

3077

1.90

28.10

3.8

2.8

ng/l

23.0

25.0

0.16

257

1537

(3021601) Nitrite [Presence] in Urine by Test strip

810

5868

1.81

27.96

5.9

4.3

estimate

0.0

0.50

150

1169

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1323

11268

2.33

27.77

4.7

3.4

mmol/l

5.9

5.6

5.76

1228

10427

(3009508) Creatinine [Moles/volume] in Urine

457

2777

1.92

27.74

3.7

3.1

mmol/l

7.3

7.2

0.06

387

2388

(3024561) Albumin [Mass/volume] in Serum or Plasma

616

4136

1.82

27.14

4.5

4.2

g/l

36.0

36.3

0.67

572

3814

(3032080) INR in Blood by Coagulation assay

516

3286

1.86

26.94

7.3

6.1

inr

1.1

0.40

158

1078

(3020682) Albumin/Creatinine [Ratio] in Urine

405

2384

1.95

26.90

4.6

4.0

mg/mmol

9.6

10.5

0.17

251

1469

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

434

2615

1.92

26.88

2.1

u/l

123.6

180.6

1.31

406

2458

(40768804) Tissue Pathology biopsy report

641

4368

1.81

26.79

2.0

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

803

5873

1.78

26.17

4.2

3.1

estimate

0.0

0.00

148

1149

(3012516) Albumin [Mass/volume] in Urine

387

2263

1.95

26.10

3.7

3.3

mg/l

643.1

349.2

0.47

241

1373

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

766

5534

1.77

25.98

4.4

3.7

—

(3048689) Calprotectin [Mass/mass] in Stool

305

1648

2.06

25.68

2.0

2.3

ug/g

99.6

104.4

0.10

224

1283

(3006315) Basophils [#/volume] in Blood

779

5674

1.76

25.52

7.3

5.9

e9/l

0.0

1.32

699

4966

(3001604) Monocytes [#/volume] in Blood

777

5664

1.76

25.30

7.2

5.8

e9/l

0.5

0.46

699

4970

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

675

4727

1.77

25.28

7.3

5.4

mmol/l

1.2

0.79

579

3987

(3013115) Eosinophils [#/volume] in Blood

804

5926

1.76

25.11

8.1

6.1

e9/l

0.2

2.49

737

5269

(3013512) EKG study

397

2370

1.91

25.03

4.1

3.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

562

3767

1.78

24.21

3.9

2.9

u/l

28.2

29.4

0.38

539

3614

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

694

4944

1.74

24.12

2.8

2.1

nmol/l

72.4

74.4

1.27

639

4587

(3016244) Insulin [Units/volume] in Serum or Plasma

5.87

23.75

2.9

4.6

mu/l

26.7

26.4

0.02

(3019198) Lymphocytes [#/volume] in Blood

797

5935

1.72

23.33

7.3

5.8

e9/l

2.0

0.94

729

5307

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

580

3973

1.74

22.84

2.1

1.8

pmol/l

100.0

97.5

0.54

307

2032

(3026782) Osmolality of Urine

322

1844

1.95

22.73

3.3

2.4

mosm/kgh2o

538.6

529.7

0.25

269

1540

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

224

1126

2.16

22.60

2.5

2.0

u/l

7900.5

6053.5

0.35

425

(3018095) Leukocytes [#/volume] in Urine

552

3743

1.74

22.44

4.3

3.1

e6/l

47.3

79.1

1.73

365

2322

(3026493) Urate [Moles/volume] in Serum or Plasma

379

2298

1.86

22.43

2.2

umol/l

1624.7

4014.1

1.32

336

2017

(3006504) Eosinophils/100 leukocytes in Blood

729

5349

1.70

22.11

7.5

5.9

2.7

2.6

0.59

684

5000

(3019069) Monocytes/100 leukocytes in Blood

732

5379

1.70

22.06

7.8

6.1

7.8

8.0

0.67

695

5067

(3042936) Bacteria identified in Isolate by Culture

247

1303

2.07

21.92

1.9

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

428

2721

1.80

21.59

2.5

2.1

mg/l

2.8

2.7

0.39

377

2342

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

604

4253

1.70

21.07

6.2

4.7

mmol/l

1.2

0.60

559

3896

(3002582) Erythrocytes [#/volume] in Urine

450

2924

1.77

20.96

3.8

2.7

e6/l

44.4

72.3

0.48

342

2114

(3019309) Folate [Moles/volume] in Red Blood Cells

275

1541

1.96

20.51

1.8

1.7

nmol/l

1189.9

1171.8

0.08

225

1150

(3044640) Blood type and Crossmatch panel - Blood

507

3433

1.72

20.26

2.4

1.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1276

11067

1.95

20.14

12.8

9.0

ml/min/173m2

92.3

90.7

1.72

1070

8813

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

176

846

2.22

19.75

1.9

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

7.84

19.58

1.3

1.5

—

(3022096) Basophils/100 leukocytes in Blood

696

5155

1.65

19.54

7.6

6.0

0.7

0.11

658

4824

(40768797) Stomach Pathology biopsy report

236

1278

2.00

19.34

1.3

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

395

2536

1.75

18.88

2.3

1.9

—

(3002030) Lymphocytes/100 leukocytes in Blood

746

5658

1.62

18.78

7.6

5.8

30.3

29.5

1.38

708

5312

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

107

421

2.66

18.64

3.6

3.0

kpa

5.1

5.2

0.78

388

(3009343) pH of Capillary blood

106

416

2.66

18.56

3.6

3.0

7.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1388

12495

2.26

18.49

16.0

9.8

mg/l

19.1

19.8

0.39

1159

9429

(3023511) Choriogonadotropin [Units/volume] in Urine

149

689

2.29

18.32

1.6

1.3

—

(3018010) Neutrophils/100 leukocytes in Blood

735

5586

1.61

18.12

7.3

5.7

56.3

56.9

0.71

700

5256

(3007164) IgA [Mass/volume] in Serum or Plasma

417

2746

1.71

18.08

1.5

1.4

g/l

2.1

0.00

256

1709

(3015377) Calcium [Moles/volume] in Serum or Plasma

506

3512

1.66

17.97

2.5

3.2

mmol/l

2.3

2.4

0.41

436

3181

(3023368) Bacteria identified in Blood by Culture

344

2162

1.76

17.54

4.3

3.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

302

1831

1.81

17.38

2.7

2.8

ng/l

743.0

989.1

0.59

241

1499

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

100

396

2.63

17.20

3.7

3.0

mmol/l

1.0

1.8

1.47

287

(3030467) Casts [#/volume] in Urine by Automated count

407

2698

1.69

17.07

3.7

2.7

e6/l

0.3

0.4

0.31

301

1938

(3007853) Bacteria identified in Skin by Aerobe culture

218

1197

1.96

17.05

1.8

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

286

1733

1.80

16.41

1.6

1.3

titre

409.3

739.9

3.92

352

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1430

13139

2.46

16.36

11.8

8.2

u/l

25.8

23.1

6.07

1393

12673

(3000850) Epithelial cells [#/volume] in Urine

316

1979

1.75

16.18

3.0

2.3

e6/l

9.8

9.2

0.26

276

1689

(40765089) Chromosome analysis panel - Blood by G-banded

6.85

16.16

1.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

268

1603

1.82

16.03

3.3

3.1

ng/l

108.1

457.6

1.95

130

963

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

611

4538

1.58

15.97

4.4

3.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

823

6543

1.56

15.91

3.6

2.7

ug/l

68.1

0.00

771

6168

(3003458) Phosphate [Moles/volume] in Serum or Plasma

193

1044

1.97

15.71

6.2

4.6

mmol/l

1.1

0.21

180

978

(3019150) Specific gravity of Urine by Refractometry

375

2481

1.68

15.65

4.3

3.4

kg/l

1.0

0.18

394

(42870588) Differential panel, method unspecified - Blood

512

3663

1.60

15.62

7.2

6.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

174

913

2.02

15.43

2.6

3.3

pmol/l

4.4

4.6

1.50

157

810

(3017143) Hepatitis C virus Ab [Presence] in Serum

275

1678

1.78

15.33

1.7

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

999

8343

1.57

15.18

3.6

2.5

u/l

42.0

33.7

2.50

961

7879

(36304419) Bacteria [Presence] in Urine

397

2697

1.64

14.84

3.6

2.6

—

(3002032) Base excess in Venous blood by calculation

137

669

2.15

14.70

6.6

3.3

mmol/l

1.0

2.0

2.29

119

539

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

324

2101

1.69

14.45

1.3

1.2

u/ml

9.0

10.0

0.11

137

849

(3030313) Adrenal Ab [Titer] in Serum

11.64

14.43

1.2

1.0

—

(3044889) 12 lead EKG panel

874

7163

1.52

13.82

3.5

2.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

127

618

2.15

13.74

2.1

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

384

2.46

13.74

1.6

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

422

2.39

13.70

5.7

3.0

g/l

130.6

128.2

0.54

411

(3000330) Specific gravity of Urine by Test strip

107

486

2.29

13.69

3.8

2.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1315

11874

1.79

13.51

4.8

3.7

mmol/l

2.8

2.9

1.42

1241

11111

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1301

11719

1.76

13.38

4.5

3.4

mmol/l

4.7

4.8

3.56

1231

11045

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

241

1473

1.76

13.23

3.4

2.4

e6/l

4.7

4.8

0.05

124

741

(40761535) Cells panel - Urine sediment

137

699

2.05

13.09

3.5

3.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

202

1177

1.83

13.01

1.2

iu/ml

155.5

159.1

0.03

474

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

254

1584

1.72

12.97

3.1

2.4

e6/l

0.9

1.2

1.18

136

849

(3005322) IgE [Units/volume] in Serum or Plasma

165

906

1.92

12.79

1.3

1.2

u/ml

748.0

229.6

0.41

153

835

(3022217) INR in Platelet poor plasma by Coagulation assay

157

850

1.94

12.68

14.9

17.5

inr

1.2

0.07

127

(3022145) Colonoscopy Study observation

177

999

1.87

12.61

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

193

2.97

12.54

4.6

3.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1244

11125

1.65

12.49

4.1

3.0

mmol/l

1.3

1.2

11.25

1168

10418

(3033658) Prothrombin time (PT) actual/Normal

369

2554

1.59

12.47

3.9

3.3

99.0

96.2

1.33

357

2478

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

336

2275

1.61

12.45

1.4

1.3

iu/ml

30.6

29.8

0.03

706

(3022313) Gas panel - Capillary blood

285

2.60

12.43

4.0

2.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

292

1915

1.65

12.29

2.3

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

316

2118

1.62

12.18

1.6

1.4

nmol/l

21.3

21.1

0.07

287

1860

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

423

3040

1.54

12.05

2.5

2.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

228

1413

1.72

11.84

3.7

3.2

mmol/l

0.8

0.02

211

1311

(3015171) Extractable nuclear Ab [Units/volume] in Serum

110

537

2.13

11.81

1.4

1.3

u/ml

0.3

1.6

1.04

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1288

11668

1.68

11.74

4.5

3.3

mmol/l

1.5

1.6

12.73

1219

10961

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

190

2.91

11.67

2.1

nmol/l

0.9

0.8

0.78

162

(3021879) Hepatitis B virus core Ab [Presence] in Serum

170

973

1.84

11.57

1.6

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

219

2.76

11.56

1.5

1.3

ug/g

332.6

293.5

0.73

102

(3041096) Erythrocytes [Presence] in Urine by Automated

455

3354

1.51

11.41

4.0

2.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

147

808

1.91

11.34

2.5

2.2

g/l

0.2

0.02

139

765

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

265

2.56

11.10

1.4

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

393

2827

1.53

11.00

4.8

4.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

305

2076

1.59

10.91

1.6

pmol/l

443.1

29516099.8

1.95

262

1755

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

280

1869

1.61

10.87

2.3

2.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

146

814

1.88

10.78

3.4

2.6

g/l

10.6

0.01

136

739

(3001556) Androgen free Index in Serum or Plasma

28.23

10.73

1.0

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

124

659

1.96

10.57

7.7

5.9

mmol/l

1.4

1.3

0.73

119

635

(3011397) Hemoglobin [Presence] in Urine by Test strip

373

2696

1.51

10.08

3.9

3.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

231

1497

1.64

10.06

2.5

2.2

umol/l

12.8

14.1

2.07

217

1380

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

374

2720

1.50

9.77

2.3

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

217

1401

1.64

9.57

1.8

1.7

—

(3000494) Fungus identified in Specimen by Culture

194

1217

1.68

9.56

1.6

1.4

—

(3021589) Normoblasts [#/volume] in Blood

659

5348

1.41

9.53

10.6

7.9

e9/l

0.0

1.30

555

4387

(3019225) pH of Specimen

141

809

1.82

9.50

6.0

3.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

209

1345

1.64

9.33

2.5

2.2

g/l

2.5

2.4

1.15

193

1232

(3000991) Gas panel - Venous blood

114

616

1.92

9.26

10.2

7.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

184

1148

1.69

9.25

2.7

2.3

umol/l

5.7

7.2

0.93

153

966

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.98

9.13

2.8

2.7

umol/l

18.5

18.4

0.01

(3035637) Corticotropin [Mass/volume] in Plasma

127

3.04

9.04

2.7

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

228

1511

1.60

9.02

1.7

1.6

1.4

1.3

1.96

204

1344

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

406

2.10

8.90

1.7

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

131

751

1.81

8.85

1.3

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

179

1122

1.67

8.83

4.7

3.2

31.0

33.2

1.61

127

787

(3002256) Pathology report gross observation

189

1203

1.65

8.79

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

230

1538

1.58

8.75

2.1

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

433

3313

1.43

8.52

1.6

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

408

3103

1.43

8.26

4.6

3.4

estimate

0.0

0.41

152

1147

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

187

1206

1.63

8.25

2.6

2.3

20.4

23.2

2.18

163

1021

(3018418) pH of Serum or Plasma

387

2916

1.44

8.24

3.8

3.3

7.4

0.20

542

(3045414) Leukocytes [Presence] in Urine

494

1.94

7.97

2.0

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

211

2.42

7.65

1.7

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

442

1.95

7.42

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

488

1.90

7.28

2.6

2.3

ug/l

6.6

6.2

0.08

428

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

111

2.92

7.19

25.0

18.1

nmol/l

1595.3

10193.1

0.49

106

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

458

3626

1.38

7.17

1.7

—

(40758558) Short blood count panel - Blood

376

2881

1.41

7.16

8.2

6.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

218

2.34

7.14

1.2

—

(3025941) Bacteria identified in Stool by Culture

117

694

1.74

7.07

1.3

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

110

643

1.77

6.99

1.8

g/l

1.3

1.4

0.28

102

583

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

133

820

1.68

6.99

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

3.25

6.99

1.2

—

(3007461) Platelets [#/volume] in Blood

1490

14424

2.57

6.94

24.8

14.7

e9/l

270.7

267.4

1.13

1470

14063

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

160

1037

1.61

6.91

6.0

5.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

370

1.99

6.82

2.1

1.8

—

(3024731) MCV [Entitic volume]

1490

14433

2.54

6.77

24.7

14.7

90.0

90.2

1.05

1482

14245

(4146454)

3.66

6.76

3.6

3.0

—

(3035941) MCH [Entitic mass]

1490

14435

2.53

6.73

24.7

14.6

29.9

30.0

2.09

1482

14245

(3009466) Valproate [Moles/volume] in Serum or Plasma

144

2.61

6.73

5.0

5.5

umol/l

366.2

381.0

0.25

122

(3026361) Erythrocytes [#/volume] in Blood

1490

14438

2.52

6.67

24.8

14.7

e12/l

4.5

4.4

1.16

1465

14064

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

423

1.92

6.65

1.9

u/l

45.0

37.8

2.29

394

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

291

2.11

6.65

1.4

1.2

u/ml

18.7

34.7

—

(3028707) Methadone [Presence] in Urine by Screen method

339

2.02

6.63

1.9

2.6

—

(3010813) Leukocytes [#/volume] in Blood

1490

14441

2.51

6.61

24.9

14.7

e9/l

6.9

6.8

1.34

1464

14053

(3025130) Human papilloma virus identified in Specimen

182

2.40

6.58

1.9

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

150

970

1.61

6.54

2.7

2.1

u/l

36.2

38.2

0.09

116

840

(3000963) Hemoglobin [Mass/volume] in Blood

1490

14446

2.49

6.52

24.9

14.8

g/l

132.1

132.2

0.14

1482

14254

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

112

673

1.72

6.48

3.1

ng/l

77.5

71.4

0.37

100

594

(3020779) Urea [Moles/volume] in Serum or Plasma

105

624

1.73

6.32

8.0

6.2

mmol/l

7.7

7.8

0.01

100

601

(3026389) Candida sp identified in Specimen by Organism specific culture

167

2.43

6.31

1.7

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

140

902

1.61

6.20

3.5

4.1

u/l

245.3

243.3

0.04

135

854

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

530

1.78

6.17

1.4

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

356

2774

1.37

6.00

1.7

1.5

mmol/l

1.5

1.3

3.56

302

2409

(36660697) Celiac disease serology panel - Serum

171

1164

1.53

5.97

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

110

679

1.67

5.78

1.1

—

137.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

128

823

1.61

5.73

6.2

6.9

kpa

13.4

13.3

0.08

123

793

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

135

880

1.59

5.71

2.2

2.3

au/ml

13.5

20.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

122

777

1.62

5.68

2.5

2.9

mmol/l

1.2

1.24

111

666

(3002385) Erythrocyte distribution width [Ratio]

1194

11080

1.36

5.63

19.3

12.4

13.5

0.06

1186

10821

(3022621) pH of Urine by Test strip

119

757

1.62

5.57

4.0

2.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

487

1.77

5.54

1.6

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

436

1.81

5.50

1.8

2.1

—

(3003396) Base excess in Arterial blood by calculation

126

816

1.59

5.48

6.4

7.0

mmol/l

0.2

1.0

1.28

101

640

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

106

2.67

5.42

16.8

11.7

mmol/l

0.6

0.03

(40761511) CBC panel - Blood by Automated count

1405

13446

1.58

5.42

15.5

9.1

—

(1002224) Polysomnography panel

433

1.79

5.33

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

353

1.88

5.30

1.4

1.3

u/ml

5.4

8.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

169

2.28

5.26

1.8

1.6

g/l

0.5

0.6

0.19

127

(3017732) Neutrophils [#/volume] in Blood

122

796

1.58

5.15

2.4

2.3

e9/l

4.2

4.1

0.07

671

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

545

1.69

5.11

1.5

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

240

1798

1.40

5.08

2.4

2.7

mmol/l

2.4

0.17

206

1578

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

110

2.57

5.06

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

110

2.57

5.06

1.1

1.2

—

(3037121) Protein [Mass/volume] in Urine

316

1.90

5.03

3.4

3.1

g/l

0.3

0.22

125

(3015235) Bicarbonate [Moles/volume] in Capillary blood

179

2.21

5.03

3.3

2.6

mmol/l

25.4

25.1

0.20

155

(3025159) Blasts/100 leukocytes in Blood

121

794

1.57

4.99

4.6

4.4

0.0

1.1

0.82

155

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

111

2.55

4.97

1.1

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

129

861

1.54

4.94

4.5

4.3

1.0

0.8

0.40

200

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

340

1.86

4.93

2.2

2.0

g/l

1.2

1.4

0.90

302

(3002179) Metamyelocytes/100 leukocytes in Blood

121

799

1.56

4.86

4.4

4.0

0.6

0.5

0.04

153

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

257

1.98

4.82

1.2

1.4

—

6.3

—

(3036489) Thrombin time

441

1.74

4.75

2.3

1.9

20.8

21.2

0.31

363

(3011288) Drugs identified in Urine by Screen method

572

1.65

4.75

2.8

2.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

218

2.05

4.70

1.2

1.3

u/ml

1.9

6.0

1.78

(3003694) ABO and Rh group [Type] in Blood

516

4371

1.27

4.60

1.8

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

342

1.82

4.55

1.8

1.7

—

(3019230) Fractional oxyhemoglobin in Venous blood

129

2.35

4.52

10.5

2.0

59.3

62.1

0.29

129

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

117

2.42

4.49

1.1

2.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

2.61

4.48

2.6

2.2

mg/l

20.8

26.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

111

2.46

4.48

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

111

2.46

4.48

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

111

2.46

4.48

1.1

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

623

1.59

4.41

2.4

2.3

g/l

66.6

67.0

0.21

567

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

594

1.60

4.33

2.1

1.8

mg/l

3.7

0.02

398

(46235355) HIV 1 and 2 tests - Meaningful Use set

502

4273

1.26

4.22

2.4

1.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

123

842

1.50

4.22

3.6

2.9

1.8

0.03

110

748

(3012494) Peanut IgE Ab [Units/volume] in Serum

3.16

4.21

1.1

u/ml

2.2

2.3

—

(3045424) Erythrocytes [Presence] in Urine

173

2.11

4.19

1.6

1.7

—

(3003181) Sodium [Moles/volume] in Urine

122

2.32

4.12

1.6

1.4

mmol/l

62.4

64.2

0.08

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.37

4.09

1.3

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.37

4.09

1.3

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

114

775

1.51

4.05

2.4

2.3

ml/min/173m2

79.1

74.3

0.72

294

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

340

1.76

4.05

4.0

2.4

g/l

3.7

3.6

0.23

318

(3021440) Promyelocytes/100 leukocytes in Blood

120

825

1.49

4.04

4.7

4.4

0.1

0.3

0.71

187

(3049717) Cytology report of Urine Cyto stain

149

2.17

4.04

1.8

2.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

427

3582

1.27

4.03

2.0

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

132

932

1.46

3.90

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.58

3.89

3.3

2.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

2.58

3.89

2.7

2.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

421

1.67

3.88

2.0

2.3

umol/l

5.2

4.5

0.32

310

(3047352) Trisomy 18 risk [Likelihood] in Fetus

124

867

1.47

3.85

1.6

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

3.81

3.80

1.8

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

2.85

3.80

1.9

1.5

nmol/l

143.6

120.8

1.92

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

385

1.69

3.79

2.6

2.0

94.4

93.8

0.08

344

(3021901) Oxygen saturation in Capillary blood

114

2.30

3.79

2.8

2.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

326

1.75

3.74

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.66

3.73

1.3

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

2.42

3.73

2.3

1.9

15.2

12.6

0.25

(3041354) Potassium [Moles/volume] in Venous blood

2.52

3.72

2.7

2.0

mmol/l

3.9

4.0

0.80

(3035285) Chloride [Moles/volume] in Venous blood

2.52

3.72

2.7

2.0

mmol/l

105.8

106.0

0.07

(3005033) Fetal Nuchal fold Thickness US

123

865

1.46

3.72

1.6

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

128

910

1.44

3.66

3.9

2.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

116

2.26

3.65

1.5

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

190

1.97

3.65

2.3

2.4

g/l

136.9

128.8

1.90

143

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.62

3.64

1.3

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

452

1.62

3.64

1.3

1.6

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

3.27

3.63

1.5

1.4

217.5

168.6

0.36

(4062490)

110

2.29

3.62

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

117

2.24

3.58

1.5

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

117

2.24

3.58

1.5

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

486

1.59

3.57

2.6

2.2

—

(3024928) Oxygen saturation in Venous blood

164

2.03

3.56

10.4

2.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

111

2.27

3.56

1.3

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

2.59

3.55

4.4

2.8

62.9

57.8

0.41

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1123

10551

1.25

3.47

4.1

3.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

131

946

1.42

3.45

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

113

2.23

3.42

1.6

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

113

2.23

3.42

1.6

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

113

2.23

3.42

1.6

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

153

2.05

3.42

1.3

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

143

1051

1.40

3.41

1.5

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

147

2.06

3.37

1.9

2.5

17.7

16.3

1.28

(1001926) Buprenorphine [Presence] in Urine by Screen method

656

1.49

3.37

1.6

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

134

2.11

3.34

3.1

4.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

124

892

1.42

3.34

1.6

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

330

1.69

3.33

1.2

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

270

1.76

3.31

2.2

1.9

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

142

1048

1.39

3.31

1.5

1.4

—

(4010399)

593

1.51

3.30

1.6

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

142

1050

1.39

3.27

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

142

1050

1.39

3.27

1.5

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

371

3130

1.25

3.26

1.8

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

184

1.92

3.26

2.9

3.9

mg/l

37.5

60.6

0.51

159

(44816559) Phosphatidylethanol [Mass/volume] in Blood

242

1.80

3.25

1.1

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

110

2.20

3.19

1.6

1.4

g/l

0.3

0.4

1.69

(3028192) IgG subclass 2 [Mass/volume] in Serum

110

2.20

3.19

1.6

1.4

g/l

2.6

2.9

0.62

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

179

1.92

3.16

2.8

3.9

—

2.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.97

3.14

1.2

1.1

103.0

89.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

111

2.18

3.13

1.6

1.4

g/l

6.3

6.8

0.36

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

261

1.75

3.09

1.6

2.3

ug/l

118.2

254.5

1.82

239

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

261

1.75

3.09

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

224

1.81

3.08

1.3

1.2

u/ml

1.8

3.5

0.97

(3016879) Cocaine [Presence] in Urine

109

778

1.43

3.08

1.8

1.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

323

1.66

3.05

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.45

3.05

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.02

3.05

1.4

1.6

—

(3019060) Gas panel - Arterial blood

451

1.56

3.00

3.4

5.4

—

(44806071)

4.30

2.99

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

380

1.60

2.98

7.0

9.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.02

2.97

1.8

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.02

2.97

1.3

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.02

2.97

1.8

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.02

2.97

1.8

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.02

2.97

1.8

1.3

—

(3011648) Oxygen content in Venous blood

2.65

2.97

1.5

2.1

10.5

10.7

0.06

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.48

2.96

1.6

1.4

—

(3011412) CD3 cells [#/volume] in Blood

114

2.12

2.95

3.8

1.9

e9/l

1.2

1.3

0.08

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

184

1.87

2.93

2.9

3.9

mg/l

27.4

49.3

0.69

158

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.60

2.87

1.2

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

164

1.91

2.86

1.3

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

149

1138

1.34

2.83

1.6

1.5

—

(3017704) Immunofixation for Urine

3.07

2.81

1.5

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

137

1.99

2.81

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

435

1.54

2.78

2.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.18

2.77

1.3

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.87

2.75

1.3

1.2

—

(4211845)

2.51

2.70

3.1

2.2

—

(3000764) Benzodiazepines [Presence] in Urine

115

851

1.38

2.68

1.7

1.9

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.67

2.62

1.9

—

(3016228) CD19 cells/100 cells in Blood

2.67

2.62

1.9

4.8

10.4

1.57

(4268621)

148

1.91

2.61

2.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

283

1.64

2.60

1.9

1.4

e6/l

60.4

1659.1

0.98

234

(3027008) Opiates [Presence] in Urine

115

857

1.37

2.58

1.7

1.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

2.20

2.57

1.3

1.2

u/l

49.2

71.6

0.63

(3003888) Timothy IgE Ab [Units/volume] in Serum

339

1.58

2.57

1.0

1.1

u/ml

3.8

6.5

1.36

188

(3009542) Hematocrit [Volume Fraction] of Blood

1281

12326

1.25

2.57

17.2

11.0

39.2

0.01

956

9878

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

193

1.78

2.55

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

115

859

1.37

2.54

1.7

1.9

—

(3004616) Nuclear Ab [Presence] in Serum

143

1.90

2.51

1.3

—

(3004451) EKG impression Narrative

3.35

2.39

1.9

1.2

—

(4281824)

2.08

2.37

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.43

2.37

2.1

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.43

2.37

2.1

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.43

2.37

2.1

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

104

2.03

2.36

2.6

3.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.51

2.36

20.3

2.2

umol/l

139.5

144.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

283

1.61

2.36

1.7

1.4

e6/l

15.3

21.6

0.21

222

(40768443) Skin Pathology biopsy report

420

1.50

2.35

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.10

2.33

2.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

269

1.62

2.31

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

112

848

1.35

2.29

1.8

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

382

1.51

2.28

1.1

u/ml

0.9

1.5

0.46

149

(3012501) Base excess in Blood by calculation

178

1.76

2.27

2.8

2.9

mmol/l

2.4

0.02

104

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.57

2.27

1.5

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

280

1.59

2.21

1.4

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

328

1.54

2.21

1.0

1.1

u/ml

0.4

1.2

1.10

145

(1761868) Lipid panel - Serum or Plasma

510

4579

1.17

2.21

2.8

2.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

107

1.98

2.21

1.6

1.9

91.5

90.4

0.46

107

(3020891) Body temperature

265

1.60

2.19

2.9

4.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.25

2.18

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

242

1.63

2.17

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

196

1.70

2.16

1.1

—

(1616796) Gas panel - Central venous blood

182

1.72

2.12

2.8

2.9

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

236

1.63

2.12

2.9

3.6

55.5

56.7

0.21

236

(21494755) Public health laboratory ask at order entry panel

137

1717

0.78

2.11

1.3

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

166

1345

1.26

2.08

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

110

1.92

2.06

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.19

2.05

1.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

138

1096

1.28

2.04

4.6

3.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

452

1.43

2.01

1.1

u/ml

2.7

5.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.82

2.00

6.3

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

248

1.59

1.99

1.3

u/ml

90.9

103.1

—

(3011436) Histone Ab [Units/volume] in Serum

3.34

1.96

1.3

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.76

1.93

2.8

3.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.74

1.93

2.1

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.74

1.93

2.1

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.74

1.93

2.1

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

331

1.50

1.93

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

150

1.75

1.91

2.5

4.3

u/ml

78.4

60.1

—

(4306422)

212

1.62

1.89

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

121

1.83

1.89

1.3

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.19

1.88

8.7

8.2

—

(3006462) Nitrate [Presence] in Urine

2.32

1.88

2.8

2.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.87

1.86

1.1

1.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

562

1.37

1.85

2.7

3.0

ng/l

121.9

158.9

0.66

507

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

222

1.59

1.83

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

130

1.78

1.82

1.1

1.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

108

1.86

1.82

1.3

1.1

ratio

1.1

1.0

—

(40768441) Liver Pathology biopsy report

1.96

1.80

1.3

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

3.05

1.80

1.0

8.2

—

(3023520) Reticulocytes [#/volume] in Blood

609

1.35

1.79

3.8

2.7

e9/l

76.8

73.0

0.32

434

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.77

1.79

1.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

216

1.59

1.77

1.5

1.4

—

(3010503) CD19 cells [#/volume] in Blood

2.10

1.76

4.6

1.9

e9/l

0.1

0.4

0.77

(3029075) Extractable nuclear Ab panel - Serum

2.45

1.75

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

209

1.59

1.74

2.7

3.1

mg/l

25.5

26.6

0.06

126

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

226

1.56

1.71

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

242

2084

1.19

1.71

1.4

—

(3044927) Protein electrophoresis panel - Urine

2.07

1.70

1.6

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

300

1.48

1.69

4.5

2.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

204

1.58

1.66

2.7

2.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

394

1.41

1.64

1.8

1.5

iu/ml

44.1

0.7

—

(3044009) aPTT.lupus sensitive (LA screen)

3.58

1.61

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.91

1.60

1.1

1.2

—

(3028433) Virus identified in Specimen by Culture

2.51

1.59

1.3

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1.96

1.59

6.5

3.4

—

(3002619) Bacteria identified in Specimen by Culture

3.01

1.58

1.2

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.86

1.56

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

265

1.48

1.54

1.3

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

3.34

1.52

1.0

u/ml

0.0

0.1

—

(3028717) Thiamine [Mass/volume] in Blood

3.34

1.52

1.0

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

259

1.48

1.49

1.9

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

753

1.28

1.48

1.5

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.51

1.45

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

117

1.72

1.45

1.4

1.7

35.2

54.2

1.30

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.13

1.44

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.13

1.44

1.0

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

110

1.74

1.43

1.1

1.2

u/l

14.2

23.8

0.64

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

149

1.62

1.41

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

181

1.56

1.40

1.5

mmol/l

9.7

11.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

230

1.49

1.39

1.1

1.0

u/ml

2.9

3.5

0.11

131

(3017569) Oxygen content in Arterial blood

2.42

1.39

2.0

2.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.78

1.39

1.2

1.1

u/l

1.3

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

101

815

1.26

1.38

2.7

4.0

ug/l

5.8

56.0

0.62

614

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.01

1.38

2.9

2.8

u/ml

381.5

1065.1

1.90

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

119

1.69

1.38

1.2

nmol/l

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

109

888

1.25

1.37

1.6

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.95

1.36

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.95

1.36

1.4

1.2

—

(3008898) HLA-B27 [Presence]

602

1.29

1.36

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

558

1.30

1.35

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

191

1.53

1.35

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

191

1.53

1.35

1.3

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.04

1.33

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

1.32

0.0

1.0

—

384.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1.74

1.31

2.4

3.7

nmol/l

0.8

0.12

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

1.31

0.0

1.0

—

56.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

1.31

0.0

1.0

—

684.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

129

1.64

1.30

1.4

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1.85

1.30

5.4

2.1

e6/l

571.6

809.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.36

1.29

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.36

1.29

1.0

—

(3023419) Bacteria identified in Sputum by Culture

1.79

1.27

3.6

2.8

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.05

1.27

1.4

2.5

u/l

169.9

183.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.86

1.24

1.3

1.5

—

(3021788) Differential panel - Synovial fluid

171

1.53

1.23

1.4

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

807

0.77

1.23

1.4

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.31

1.18

1.0

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.11

1.18

1.1

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

501

1.29

1.15

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

134

1.58

1.14

3.9

4.1

u/ml

89.8

828.0

0.72

126

(3002523) Influenza virus A Ag [Presence] in Specimen

267

1.40

1.13

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

122

1030

1.20

1.13

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.34

1.12

1.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.34

1.12

1.9

2.3

—

(3022689) Creatine [Moles/volume] in Urine

2.34

1.12

1.3

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

1.37

1.10

1.6

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

1.37

1.10

1.6

2.2

g/l

4.1

3.8

0.43

213

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

1.37

1.10

1.6

2.2

g/l

7.0

7.5

0.98

222

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.26

1.10

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

277

1.38

1.10

1.5

2.2

g/l

10.3

10.4

0.06

235

(3014271) Vancomycin [Susceptibility]

2.39

1.09

6.8

3.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.39

1.09

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.39

1.09

1.2

1.1

—

(4027681)

112

1.61

1.09

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

382

1.32

1.08

2.5

2.0

iu/l

2.9

4.8

1.61

165

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.19

1.08

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

955

0.81

1.07

2.0

1.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

138

1.53

1.03

1.2

1.1

mg/l

39.7

32.8

0.67

111

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

1.61

1.03

1.5

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.74

1.03

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

188

1.44

1.01

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.65

1.00

2.2

1.8

—

(4035726)

814

1.20

0.98

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

132

1.52

0.97

1.2

1.0

mg/l

233.3

211.4

0.55

114

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.95

0.97

1.3

2.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.95

0.97

1.1

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

157

1.47

0.96

1.4

1.6

—

(3042631) Mycobacterium sp identified in Specimen

1.67

0.91

2.0

1.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1.60

0.90

1.1

1.2

—

70.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.60

0.90

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

202

1.39

0.89

1.3

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

177

1.42

0.88

1.9

2.4

ug/min

50.9

87.3

0.44

105

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.58

0.87

1.1

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.58

0.87

1.6

1.3

g/l

0.8

0.9

2.00

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1039

0.84

0.87

1.5

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.72

0.86

1.0

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

275

1.32

0.82

1.6

2.3

g/l

2.9

3.2

1.77

217

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.74

0.82

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.88

0.82

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

105

1.53

0.81

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

206

1.37

0.81

2.5

2.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

267

1.32

0.81

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

267

1.32

0.81

1.2

u/ml

243.2

256.8

0.14

179

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

0.00

0.79

0.0

1.3

—

34.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

402

1.25

0.79

1.5

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

131

1.46

0.78

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

148

1.42

0.78

1.1

—

(3023410) Appearance of Cerebral spinal fluid

140

1.43

0.77

2.3

1.5

—

(3000492) Spirometry study

122

1071

1.15

0.76

1.3

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.09

0.74

1.2

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

150

1.41

0.73

1.1

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

281

1.29

0.73

1.3

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

281

1.29

0.73

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.00

0.72

2.8

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.00

0.72

1.4

2.3

—

(3024471) HLA-A [Type]

2.00

0.72

1.0

—

(3024932) HLA-DR beta [Type]

2.00

0.72

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.80

0.72

1.0

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

220

1.32

0.71

1.7

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

327

1.26

0.71

1.0

1.1

u/ml

1.3

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

274

1.28

0.70

2.3

3.5

u/ml

191.7

332.5

0.27

230

(40768793) Breast Pathology biopsy report

420

0.78

0.69

1.3

—

(3037756) Immunofixation for Serum or Plasma

135

1.41

0.69

2.3

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.60

0.68

1.5

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

102

1.48

0.67

1.6

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.79

0.66

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.79

0.66

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

198

1.32

0.64

1.5

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.50

0.63

2.2

1.4

—

(3045142) Bone marrow Pathology biopsy report

1.50

0.63

1.2

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.67

0.61

1.0

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.67

0.61

2.4

2.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

191

1.31

0.61

11.5

3.2

u/ml

0.3

0.4

0.54

112

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

380

1.22

0.61

1.3

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1.48

0.60

1.2

1.7

50.4

42.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

236

1.28

0.60

1.6

2.0

g/l

38.9

37.8

0.48

207

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.54

0.59

1.3

1.2

u/l

21.9

17.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.72

0.57

1.2

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.48

0.57

1.3

1.2

u/l

93.8

73.2

—

(3051611) Lipemic interference index of Serum or Plasma

1.43

0.56

8.7

2.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.43

0.56

2.1

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.62

0.55

1.3

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.62

0.55

1.3

1.8

—

(4024509)

1.45

0.55

1.5

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

133

1.36

0.55

1.4

—

(3051651) Icteric interference index of Serum or Plasma

1.48

0.53

12.4

2.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

629

0.85

0.52

2.4

2.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.50

0.51

1.8

1.9

—

(44806118)

109

1.38

0.51

1.4

—

(44790047)

109

1.38

0.51

1.4

—

(44790048)

109

1.38

0.51

1.4

—

(44790049)

109

1.38

0.51

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

252

1.23

0.50

1.7

2.3

g/l

0.3

0.9

1.07

220

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.50

0.49

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.50

0.49

6.1

5.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.56

0.49

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.52

0.48

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

119

1.35

0.48

1.2

1.3

—

(44813793)

102

1.38

0.47

1.1

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.46

0.46

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

191

1.26

0.46

1.5

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

287

0.80

0.46

1.3

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.43

0.45

1.1

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

103

1.36

0.45

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

1.37

0.44

1.0

1.7

—

18.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

274

0.80

0.43

2.9

3.6

u/ml

25.6

33.8

0.40

269

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.41

0.43

4.5

6.9

—

(3020650) Glucose [Presence] in Urine

1.61

0.43

1.2

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

149

1.28

0.42

1.5

1.6

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.41

0.0

7.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.37

0.40

1.2

1.1

miu/ml

1441.2

1546.6

0.11

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

0.40

0.0

6.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

105

0.67

0.39

1.0

1.1

—

(4198724)

1.41

0.39

4.8

2.1

—

(21494434) Karyotype in Bone marrow

1.35

0.38

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.33

0.37

1.4

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

219

2073

1.07

0.37

1.6

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.35

0.37

1.2

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.32

0.35

1.5

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

282

1.17

0.35

1.0

1.1

u/ml

3.5

4.6

—

114

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

153

1.24

0.35

1.9

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

126

0.71

0.35

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.32

0.33

1.5

2.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.67

0.32

1.5

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.67

0.32

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.32

0.31

1.1

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.27

0.30

1.3

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.23

0.29

1.1

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.23

0.29

1.4

1.5

—

6.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.23

0.29

1.3

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

131

1389

0.94

0.27

1.6

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

104

1.25

0.26

1.2

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.28

0.26

1.4

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

263

1.14

0.25

1.0

1.1

u/ml

2.7

4.1

—

112

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.25

0.25

1.1

1.2

—

(4094501)

161

1.18

0.24

1.1

1.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.74

0.24

1.0

2.3

33.2

32.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.32

0.23

1.4

1.1

93.6

94.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.32

0.23

1.4

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

4.1

—

2.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.21

0.0

7.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.21

0.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

4.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.20

0.19

1.3

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.20

0.19

1.3

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.20

0.19

1.3

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.15

0.17

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

267

0.90

0.16

2.2

1.6

mmol/l

8.3

6.8

1.31

195

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

139

1.15

0.16

3.3

4.2

u/ml

146.1

41.2

0.47

139

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.13

0.15

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

305

0.92

0.13

2.0

1.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

968

0.96

0.13

1.5

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

157

0.89

0.11

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

271

1.07

0.09

1.4

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.06

0.09

1.4

1.1

115.2

108.5

—

(3035933) Granulocytes/100 leukocytes in Blood

1.04

0.09

1.8

1.2

—

(3034426) Prothrombin time (PT)

1.09

0.09

1.0

1.2

—

(3012441) Differential panel - Pleural fluid

0.79

0.08

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

156

1.09

0.08

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.03

0.07

1.3

1.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.80

0.07

1.3

2.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

1.04

0.07

1.3

1.4

g/l

32.6

32.8

—

(3015183) Erythrocyte sedimentation rate

0.83

0.07

1.6

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

316

0.95

0.07

2.1

1.7

mmol/l

7.5

7.4

0.09

194

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

122

0.90

0.07

1.7

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

183

0.93

0.06

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

111

1.08

0.04

1.0

1.2

—

(4034850)

340

1.03

0.03

10.5

5.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

118

0.93

0.02

1.1

1.6

—

(3044941) Cell count panel - Synovial fluid

147

0.95

0.01

1.3

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.04

0.00

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

104

0.96

0.00

1.3

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

138

1.01

0.00

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

784

0.99

0.00

1.4

1.3

miu/ml

239.9

232.4

0.06

418

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.1

—

38.6

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

5.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.4

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.0

—

71.1

—

(3045788) Cell count panel - Pleural fluid

0.85

0.00

1.6

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

11.5

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.0

2.4

—

173.7

—

(40768806) Pleura Pathology biopsy report

0.85

0.00

1.4

1.6

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.0

—

(3025315) Body weight

0.00

0.0

6.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.00

0.0

12.6

—

6.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

208.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.90

0.00

1.2

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.85

0.00

1.0

1.1

iu/ml

59.1

163.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.90

0.00

1.4

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.4

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_OLIGOMEN and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_OLIGOMEN	1.895 [1.58, 2.27]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.28

During the follow-up period (1.1.1998 — 31.12.2019), 173 out of 6209 females with N14_OLIGOMEN died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_OLIGOMEN.

N-year risk	Females	Males
1	0.161%	No data
5	1.097%	No data
10	2.978%	No data
15	5.38%	No data
20	9.245%	No data

Relationships between endpoints

↥

Index endpoint: N14_OLIGOMEN – Oligomenorrhoea

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Oligomenorrhoea

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints